Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

Radiotherapy 4Cisplatin 4Paclitaxel 3Gemcitabine 3Fluorouracil 3Oxaliplatin 2fluoromisonidazole 1dl1520 1Semaxinib 1Rubidium-82 1Ritonavir 1Nivolumab 1Nicotine 1Magnetic Resonance Spectroscopy 1Leucovorin 1Irinotecan 1Indinavir 1Immunohistochemistry 1Fluorodeoxyglucose F18 1Filgrastim 1Endoscopic Mucosal Resection 1EBV-associated membrane antigen, Epstein-Barr virus 1Docetaxel 1Bronchoscopy 1Bortezomib 1Amifostine 15-fluoropentyl-2-methylmalonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Nasopharyngeal Neoplasms × dl1520 × Clear all
NCT00006106 2013-07-10

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Withdrawn
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡